Importance of Lid Hygiene Before Ocular Surgery: Qualitative and Quantitative Analysis of Eyelid and Conjunctiva Microbiota by Peral Cerdá, Assumpta et al.
ARTICLE
Importance of Lid Hygiene Before Ocular Surgery:
Qualitative and Quantitative Analysis of Eyelid and
Conjunctiva Microbiota
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and Patricia Calvo del Bosque, M.Sc.
Objective: To evaluate the efﬁcacy of a cleansing eyelid wipe in reducing
the microbiota present on the ocular surface before cataract surgery.
Methods: A single-center, prospective, single-blind phase IV study was
conducted at the University Complutense of Madrid. Forty-ﬁve adult
patients who were scheduled for ocular surgery after treatment with
commercially available eyelid wipes were consecutively enrolled. The
study lasted 5 days and the patients were examined at day 0 (D0), day 3
(D3), and day 5 (D5). They received instructions to apply the eyelid wipe
only to the eye subject to surgery, using the other eye as a control with no
treatment. Lid and conjunctival swabs were taken on each day and microbes
identiﬁed. Ocular surface microbiota was estimated by measuring the area
of the agar plate occupied by the grown colonies with respect to the total
available area.
Results:Measurements at D3 and D5 showed a percent reduction of 58%
and 63%, respectively, in the microbial load on the eyelid in the treated
eyes (P¼0.0011). There was also a reduction, although nonsigniﬁcant, in
the microbiota of the conjunctiva of 72% and 69% on D3 and D5,
respectively.
Conclusions: The degree of microbiota reduction was comparable with that
obtained after topical application of antibiotics in other studies. The results
suggest the use of these eyelid wipes as a complementary prophylactic
method before any ocular surgery.
Key Words: Ocular surface microbiota—Eyelid wipe—Cataract surgery—
Ocular surgery.
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I ntraocular postoperative infections are a permanent concernfor every eye surgeon. Although postoperative endophthal-
mitis is infrequent, with an incidence rate of 0.06% to 0.09% in
the last decade,1–7 it represents a devastating complication in
ophthalmic surgery.8 For this reason, the search for optimal
procedures that will help reduce its incidence is a constant chal-
lenge.
Although the incidence of postoperative infections has a low
rate, an increasing number of cases are now occurring after
intravitreal injections of antivascular endothelial growth factor
(VEGF) medications for choroidal neovascularization related to
age-related macular degeneration,9–11 diabetic cystoid macular
edema,12,13 and retinal vein occlusion.14 In fact, current protocols
for the treatment of neovascular age-related macular degeneration
dictate monthly or near-monthly injections of anti-VEGF.15 The
risk of endophthalmitis reported after intravitreal injections is
between 0.022% and 0.16%.16,17
The etiologic agents of acute postoperative endophthalmitis
are generally microorganisms of the eyelid margin, conjunctiva,
and tear ﬁlm.18 The normal microbiota from the eyelid and con-
junctiva has already been described.19 The most common bacte-
ria isolated from the eyelids, conjunctiva, and tears are gram-
positive bacteria, mostly coagulase-negative Staphylococcus
spp. Depending on the study, the frequency of isolation of bac-
teria ranges from 16% to 100%, with microbial growth shown in
approximately 50% of swabs from the conjunctiva and tears, and
more than 50% of swabs from eyelids.19 The most commonly
isolated microbes are Staphylococcus epidermidis, Corynebacte-
rium spp, Staphylococcus aureus, Pseudomonas spp, or Proteus
spp, which also have been isolated from intraocular infections.
Bacteria present on the eyelid are responsible for acute postop-
erative endophthalmitis.18,20
To prevent the onset of postoperative endophthalmitis, several
prophylactic strategies have been used. These approaches, which
often feature use of topical antibiotics, are focused on reducing the
bacterial load on the ocular surface assuming this could reduce the
risk of endophthalmitis.8,21 The most commonly used treatments
are perioperative topical antibiotics, preoperative topical antibiot-
ics, intracameral antibiotics, antibiotics at the end of the surgery,
and postoperative topical antibiotics.22 In addition to antibiotics,
the antiseptic povidone–iodine (PVI) 5% to 10% is topically
applied to the cornea, the conjunctival sac, and to the periorbital
area. Several studies have demonstrated that PVI reduces the mi-
crobiota in the conjunctiva.7,8,21,23
From the Department of Optometry and Vision (A.P., C.N.-R., P.C.d.B.),
Faculty of Optics and Optometry, University Complutense of Madrid,
Madrid, Spain; Department of Optics (J.A.), Faculty of Optics and
Optometry, University Complutense of Madrid, Madrid, Spain; Department
of Microbiology II (C.G.-G.), Faculty of Optics and Optometry, University
Complutense of Madrid, Madrid, Spain.
The authors have no conﬂicts of interest to disclose.
Supported by the eyelid wipes were supplied by Thea Laboratories
(Barcelona, Spain).
Presented at the Association for Research in Vision and Ophthalmology
(ARVO) 2014 Annual Meeting, May 4–8, 2014, Orlando, FL.
Address correspondence to Assumpta Peral, Ph.D., Faculty of Optics and
Optometry, University Complutense of Madrid, Avenida Arcos de Jalón
118 28037, Madrid, Spain; e-mail: Assumpta@ucm.es
Accepted October 5, 2015.
Copyright  2015 Contact Lens Association of Ophthalmologists. This is
an open access article distributed under the terms of the Creative Commons
Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND),
which permits downloading and sharing the work provided it is properly
cited. The work cannot be changed in any way or used commercially.
DOI: 10.1097/ICL.0000000000000221
366 Eye & Contact Lens  Volume 42, Number 6, November 2016
This study tested the efﬁcacy of lid hygiene using commercially
available cleansing wipes to reduce the ocular surface microbiota in
patients before ocular surgery.
METHODS
This study adhered to the Helsinki Declaration and the Good
Clinical Practice (GCP) guidance and was approved by the
Research Ethics Committee of the Hospital Clínico San Carlos
(Madrid, Spain). All patients gave written informed consent.
This single-center, prospective, single-blind phase IV study
included adults of either sex, who were scheduled for ocular
surgery after the treatment. Exclusion criteria included any kind of
ocular or systemic disease, past or present, and any ocular and/or
systemic treatments/antibiotics within the last 6 months.
The study lasted 5 days and the patients were examined at day
0 (D0), day 3 (D3), and day 5 (D5). The 5-day treatment was
applied to only 1 eye that is, the eye selected for surgery; the
other eye served as control with no treatment applied. Patients
were instructed to apply heat over the eye for 4 min. A small
towel was heated in a microwave on full power for 10 to 15 sec
(which rises towel temperature to approximately 40°C) which
was repeated every 2 min. It was applied to the closed eye area
with sufﬁcient pressure to ensure that the towel remained in
contact with the eyelids. Then patients massage, applying
a gently pressure, the upper lid “inward–downward” and the
lower lid “inward–upward,” to mobilize the debris adhered to
the eyelashes and meibum, and ﬁnally they use a sterile eyelid
wipe and slide it across the eyelid from the inside to the outside,
to clean the upper and lower lids. The Blephaclean (Laboratoires
Théa, Clermont-Ferrant, France) sterile wipes contain a solution
of hyaluronic acid, capryloyl glycine, iris ﬂorentine, and cen-
tella asiatica. Hyaluronic acid can inﬂuence cell proliferation,
differentiation, and dermal tissue repair.24 Capryloyl glycine
and iris ﬂorentine extracts are natural emollients show antibac-
terial activity and present a sebum-regulator effect and centella
asiatica acts repairing dermal tissue, increasing collagen pro-
duction, and activating blood circulation.25
They were used twice-a-day for 5 days in the selected eye.
Visual acuity was measured at D0 and D5, and a slit-lamp
examination was performed in each visit, to ensure there was no
adverse reaction on the treated tissues.
Procedures and Assessments
Microbiota samples were taken from the surface of the lower lid
and the inferior conjunctival sac fundus of both eyes at D0, D3, and
D5 using sterile swabs moistened with saline solution without
administering topical anesthesia. The nontreated eye was used as
a control and microbiota samples were obtained in the same way.
Sterile gloves were used when taking the samples.
Samples were cultured in speciﬁc media on blood and chocolate
agar plates and incubated aerobically for 48 hr at 37°C. Sterile cotton
swabs (Materlab SL, Madrid, Toledo, Spain) were used wet with
50 mL of saline solution. The volume of saline was controlled and
applied by a pipette. Initially a sample from the eyelid was taken and
spread onto 1 semipart of the dish and, by the same procedure, another
cotton swab was taken from the conjunctival sac of the conjunctiva
and seeded onto the other semipart of the dish. Dishes were divided in
two semiparts; the left side corresponding to the eyelid culture and the
right side to the conjunctiva. Grown colonies were photographed with
a high-resolution digital camera, and the total area of microbial growth
on the plates was analyzed by ImageJ software.
The percentage of the area occupied by the colonies was
determined as follows: (1) The original image of the plate, shown
on the left side of Figures 1 and 2, is a full RGB TIFF, which was
converted to 8-bit grayscale. Figure 2 shows full images of the
dishes. The upper plates belong to the right eye and the lower
plates to the left eye. (2) A mask was created by marking out the
region where the colonies may grow. The mask is a semicircle
covering half the plate, corresponding to the region in which the
colonies from the lid or the colonies from the conjunctiva were
grown. (3) The selected region is transformed to 1-bit image by
selecting an adequate threshold. The contrast between the colonies
and the background (culture medium) was very good and a sharp
contour of the colonies was achieved. The ﬁnal image is shown in
Figure 1 (right). Black pixels correspond to colonies, and white
pixels correspond to the culture medium. (4) The ratio of the area
occupied by the colonies and the total available growing region
was obtained as the ratio of the number of pixels set to 0 and the
number of pixels set to 1.
Once the photographs of the dishes were taken, microorganisms
were identiﬁed by Gram staining, catalase, coagulase, DNase, and
mannitol fermentation tests.
Statistical Analyses
Data are presented as mean6SD. Differences in microbiota
numbers between D0, D3, and D5 were assessed using the Student
t test, assuming a signiﬁcance level of 0.05.
RESULTS
The study included 45 consecutive patients (17 men, 28 women)
with a mean age of 53.866.3 years (range 45–73 years). Visual
FIG. 1. Counting mask. Detail of eyelid colonies. Image corre-
sponds to patient #39.
Eye & Contact Lens  Volume 42, Number 6, November 2016 Analysis of Eyelid and Conjunctiva Microbiota
 2015 Contact Lens Association of Ophthalmologists 367
acuity in the treated eye was in a range between 1.0 and 0.54
logMAR and remained stable during the treatment, and the slit-
lamp examination showed no adverse reaction on the treated
tissues.
Microorganisms Present in the Eyelid
and Conjunctiva
At D0, microbial analysis demonstrated similar proﬁles for
eyelid and conjunctiva. Identiﬁed microbiota is shown in Table 1.
The eyelid showed the presence of S. epidermidis and Corynebac-
terium spp (94.7% and 32.98% of the plates, respectively) as the
most frequent microorganisms. In a smaller percentage, S. aureus,
Micrococcus spp, and Bacillus spp (6.38%, 8.51%, and 1.06%,
respectively) were isolated. From the conjunctival swabs, S. epi-
dermidis and Corynebacterium spp (54.26% and 38.29%) were
identiﬁed as well as S. aureus and Micrococcus spp (5.32% and
1.06%).
Microbiota Reduction
The microbial area of growth on the plates was measured
according to the method described in the methods section. A
photograph of a typical petri dish, along with the mask used for
measuring the area occupied by the colonies is shown in Figure 1.
The colonies’ area analysis yielded a higher microbial load from the
eyelids (17.9%) compared with the conjunctiva (1.4%) in most of the
samples, as it is seen in Figure 2. Percent reduction in microbial load
on the eyelid in the treated eyes was 58% at D3 and 63% at D5 63%
(P¼0.001) (Fig. 3). The microbiota of the conjunctiva was lower
than that of the eyelid. There was a reduction, although nonsignif-
icant, of 72% and 69% at D3 and D5, respectively (Fig. 4) in the
numbers of microbes on the conjunctiva. Table 2 and Figures 1 and
2 show the microbiota growing areas from eyelid and conjunctiva in
all groups. There were no differences by sex.
DISCUSSION
In addition to the classical procedures such as cataract surgery,
the number of intraocular interventions is increasing because of the
development of new therapies. Endophthalmitis caused by micro-
organisms present on the ocular surface may occur as a conse-
quence of these treatments. The results obtained in this study
demonstrated a signiﬁcant reduction in the microbiota present on
the lids and conjunctiva after 3 days of rubbing the lids with the
wipes, demonstrating the importance of lid hygiene before ocular
surgery or an intraocular procedure, as a complementary pro-
phylactic approach.
The percentages of microorganisms existing on the eyelids and
conjunctiva in the study were similar to that described previously
with the most commonly isolated bacteria being coagulase-
negative staphylococci and, more speciﬁcally, S. epidermidis fol-
lowed by Corynebacterium spp Between 20% and 80% of swabs
from the conjunctiva and between 30% and 100% of swabs from
the lids showed growth of the bacteria S. epidermidis.19 Carron
et al.26 found the most common bacteria were coagulase-negative
FIG. 2. Dishes are divided in two
semiparts: the left sides correspond to
the eyelid culture and the right sides to
the conjunctiva, the upper plates
belong to the right eye and the lower
ones to the left. Image corresponds to
patient #39.
TABLE 1. Microbiota Profiles for Eyelid and Conjunctiva Before Treatment
Staphylococcus epidermidis Corynebacterium spp Staphylococcus aureus Micrococcus spp Bacillus spp
Eyelid (%) D0 94.70 32.98 6.38 8.51 1.06
Conjunctiva (%) D0 54.26 38.29 5.32 1.06 0.00
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staphylococci (66.7%), followed by Corynebacterium spp (11.5%)
from the conjunctiva, and Li et al.27 described a prevalence of
62.9% and 32.4% for S. epidermidis and Corynebacterium spp,
respectively, from the conjunctiva. Vasavada et al.28 detected
between 90.4% and 94.4% of Staphylococcus species from the
conjunctiva, of which 71% were S. epidermidis. The rate of iso-
lation of the same bacteria in the study by Höﬂing-Lima et al.29
ranged between 50% and 80% for the conjunctiva and between
76% and 100% for the eyelids.
The microbial isolation of the conjunctiva was reduced on
presurgical prophylaxis of wiping the eye after brieﬂy heating the
eye. Hueso Abancens et al.30 presented a similar study analyzing
the use of palpebral cleansing solution with capryloyl glycine over
the conjunctiva microbiota. A clinical reduction was seen from the
third day of applying the cleansing solution that lasted until day 5.
In the study of Hueso Abancens et al.,30 the maximum reduction
obtained after 5 days of treatment was approximately 10% and the
main bacteria was Staphylococcus spp coagulase-negative. The
smaller reduction found by Hueso Abancens et al.30 than this study
could be due to the hygiene protocol used to clean the lids. In the
study by Hueso Abancens et al.,30 the patients were not told to
apply heat and massage the lids before using the cleansing solution.
In addition, many studies have been conducted on the reduction
of eyelid and conjunctiva microbiota after the application of
different antibiotics on their own or in combination with PVI.
Höﬂing-Lima et al.29 examined the efﬁcacy of topical lomeﬂoxacin
0.3% and tobramicin 0.3% 3 days before cataract surgery in reduc-
ing biota, and showed statistical reductions in conjunctiva of
66.7% and in lid biota of 3.9% with lomeﬂoxacin, and of 75%
and 34.5%, respectively, with tobramicin.
Carron et al.26 described a 4.3% reduction in conjunctiva biota
after the administration of ciproﬂoxacin 0.3% 1 day before cataract
surgery that increased to 60.9% after the application of PVI. The
use of PVI before cataract surgery has become a standard of care
and a mandatory step in reducing ocular surface microbiota. Apt
et al.31 showed a 91% reduction in the number of colonies of the
conjunctiva after the application of PVI. Halachmi-Eyal et al.32
reported a 38% reduction after the application of PVI 3 min before
surgery and a 34% reduction with the topical application of moxi-
ﬂoxacin 0.5% 2 hr before surgery and PVI 3 min before surgery.
The percentage reductions in the microbiota from this study are
comparable in some ways to those obtained after the application of
topical antibiotics. Eyelid hygiene did not sterilize the tissue, it just
decreased the number of bacteria present in the external tissue of
the eye without modifying the composition of saprophytic biota on
both eyelids and conjunctiva. The reason for these reduced values
is probably due to the hygiene protocol that patients followed of
cleaning their eyelids after the application of heat and the massage.
Although microbiota is present in eyelids and conjunctiva, the
percentage of area covered by colonies shows an important microbial
load from the eyelids, which highlights the need to maintain
preoperative and postoperative asepsis of both eyelid and conjunctiva.
Results obtained from bacteria cultures can indicate the type of
antibiotic prophylaxis to use for minimizing ocular postoperative
infections: broad-spectrum antibiotics or, preferably, antibiotics
with speciﬁc activity against gram-positive bacteria.
TABLE 2. Mean Values of Microbiota Growing Areas From Eyelid and
Conjunctiva for Days 0, 3, and 5
Days of treatment Mean (%)6SD
Eyelid
Treated Nontreated
D0 17.8966.7 16.6866.2
D3 7.3565.3 16.5468.6
D5 6.5765.6 15.5567.8
Conjunctiva
Treated Nontreated
D0 1.3662.8 1.3862.7
D3 0.3861.1 0.9962.6
D5 0.4161.4 0.8862.3
FIG. 3. Eyelid microbiota throughout the study (D0, D3, and D5)
for the treated eye (TE) and the nontreated eye (NTE). Bars represent
mean6SD. Differences between TE and NTE were statistically sig-
nificant (P,0.0001).
FIG. 4. Conjunctiva microbiota throughout the study (D0, D3, and
D5) for the treated eye (TC) and the nontreated eye (NTC). Bars
represent mean6SD. No statistically significant differences were
found between TC and NTC.
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Eyelid hygiene cannot replace general preoperative procedures
focused on preventing contamination, such as the use of PVI
solutions for eyelids and conjunctiva or antibiotics. Nevertheless,
eyelid hygiene can be used as a complementary prophylactic
approach to prevent endophthalmitis.
The use of cleansing eyelid wipes may help in the case of
undiagnosed blepharitis before cataract surgery or other kinds of
ocular surgery, as they could also reduce the risk of postoperative
endophthalmitis.
Further studies are needed regarding the convenience of the
medical regimen of use 3 and 5 days before surgery; the time the
microbiota takes to recover itself after the use of the eyelid wipes;
and what occurs if the patient uses the wipes more than 5 days.
Another aspect worthy of study is the usefulness of applying the
eyelid wipes as a postoperative prophylaxis or the medical regimen
of use. This study demonstrated that the application of heat and
a massage to the eyelids before the use of the eyelid wipe improves
the reduction in the microbiota present in the ocular surface in 5
days, and eyelid hygiene can be use as a complementary pro-
phylactic approach to prevent ocular infections.
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